Michael Golembiewski
2021
In 2021, Michael Golembiewski earned a total compensation of $1.1M as Chief Financial Officer at Apricus Biosciences.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $97,350 |
| Option Awards | $720,461 |
| Salary | $281,667 |
| Other | $12,917 |
| Total | $1,137,395 |
Golembiewski received $720.5K in option awards, accounting for 63% of the total pay in 2021.
Golembiewski also received $25K in bonus, $97.4K in non-equity incentive plan, $281.7K in salary and $12.9K in other compensation.
Rankings
In 2021, Michael Golembiewski's compensation ranked 8,342nd out of 12,415 executives tracked by ExecPay. In other words, Golembiewski earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,342 out of 12,415 | 33rd |
Division Manufacturing | 3,691 out of 5,508 | 33rd |
Major group Chemicals And Allied Products | 1,639 out of 2,378 | 31st |
Industry group Drugs | 1,458 out of 2,099 | 31st |
Industry Pharmaceutical Preparations | 1,085 out of 1,549 | 30th |
Source: SEC filing on April 12, 2022.
Golembiewski's colleagues
We found one more compensation record of an executive who worked with Michael Golembiewski at Apricus Biosciences in 2021.
2021
Raj Mehra
Apricus Biosciences